IBDEI0L7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10393,0)
 ;;=V10.62^^67^675^43
 ;;^UTILITY(U,$J,358.3,10393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10393,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,10393,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,10393,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,10394,0)
 ;;=V10.63^^67^675^41
 ;;^UTILITY(U,$J,358.3,10394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10394,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,10394,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,10394,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,10395,0)
 ;;=V11.2^^67^675^32
 ;;^UTILITY(U,$J,358.3,10395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10395,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,10395,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,10395,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,10396,0)
 ;;=V15.81^^67^675^60
 ;;^UTILITY(U,$J,358.3,10396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10396,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,10396,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,10396,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,10397,0)
 ;;=V10.43^^67^675^44
 ;;^UTILITY(U,$J,358.3,10397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10397,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,10397,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,10397,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,10398,0)
 ;;=V12.71^^67^675^45
 ;;^UTILITY(U,$J,358.3,10398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10398,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,10398,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,10398,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,10399,0)
 ;;=V10.46^^67^675^48
 ;;^UTILITY(U,$J,358.3,10399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10399,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,10399,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,10399,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,10400,0)
 ;;=V11.0^^67^675^50
 ;;^UTILITY(U,$J,358.3,10400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10400,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,10400,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,10400,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,10401,0)
 ;;=V10.83^^67^675^51
 ;;^UTILITY(U,$J,358.3,10401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10401,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,10401,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,10401,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,10402,0)
 ;;=V15.1^^67^675^53
 ;;^UTILITY(U,$J,358.3,10402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10402,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,10402,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,10402,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,10403,0)
 ;;=V15.82^^67^675^57
 ;;^UTILITY(U,$J,358.3,10403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10403,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,10403,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,10403,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,10404,0)
 ;;=V12.01^^67^675^54
 ;;^UTILITY(U,$J,358.3,10404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10404,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,10404,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,10404,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,10405,0)
 ;;=V13.01^^67^675^36
 ;;^UTILITY(U,$J,358.3,10405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10405,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,10405,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,10405,2)
 ;;=Hx of Kidney Stones^303403
